Chronic demyelinating neuropathy with anti-myelin-associated glycoprotein antibody without any detectable M-protein View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-12

AUTHORS

Yuki Sakamoto, Toshio Shimizu, Shinsuke Tobisawa, Eiji Isozaki

ABSTRACT

Previous case reports and studies have shown that anti-myelin-associated glycoprotein (MAG) antibody can be detected in patients with polyneuropathy without any detectable M-protein. Nevertheless, the frequency of and related factors have not yet been adequately investigated. The objectives of this study are to examine the prevalence of anti-MAG antibody in patients with demyelinating neuropathy without M-protein and to determine their clinical characteristics. From January, 2004, to September, 2016, consecutive patients with chronic demyelinating neuropathy were recruited. Anti-MAG antibody presence was tested at the first evaluation. We determined the prevalence of anti-MAG antibody without M-protein among included patients and evaluated the clinical characteristics. A total of 44 patients were included in the present study (12 women; median age at first visit 60 years [interquartile range 47-67 years]; median duration between onset and first visit 9 months [3-26 months]). M-protein was found in eight patients (18%) at the first evaluation. Anti-MAG antibody was present in 2 of remaining 36 (5.6 [95% confidence interval 0-13.0] %) patients without M-protein. Patients with anti-MAG antibody exhibited slowly progressive and distal dominant neuropathy with elevated serum IgM levels and refractory to immunotherapy. There were no differences in clinical features between patients having anti-MAG antibody without M-protein, and those with M-protein. One patient with the anti-MAG antibody showed a delayed appearance of M-protein during a 4-year follow-up after diagnosis. The prevalence of the anti-MAG antibody in chronic demyelinating neuropathy without any detectable M-protein was 5.6%. Anti-MAG antibody may be detectable earlier than M-protein. More... »

PAGES

2165-2169

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10072-017-3133-0

DOI

http://dx.doi.org/10.1007/s10072-017-3133-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1092057625

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28980134


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Autoantibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Connectin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin M", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myelin-Associated Glycoprotein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prevalence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Failure", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Nippon Medical School", 
          "id": "https://www.grid.ac/institutes/grid.410821.e", 
          "name": [
            "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1, Musashidai, 183-0042, Fuchu, Tokyo, Japan", 
            "Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sakamoto", 
        "givenName": "Yuki", 
        "id": "sg:person.01011567726.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011567726.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tokyo Metropolitan Neurological Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417106.5", 
          "name": [
            "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1, Musashidai, 183-0042, Fuchu, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shimizu", 
        "givenName": "Toshio", 
        "id": "sg:person.015551645122.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015551645122.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tokyo Metropolitan Neurological Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417106.5", 
          "name": [
            "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1, Musashidai, 183-0042, Fuchu, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tobisawa", 
        "givenName": "Shinsuke", 
        "id": "sg:person.01121612173.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121612173.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tokyo Metropolitan Neurological Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417106.5", 
          "name": [
            "Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1, Musashidai, 183-0042, Fuchu, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Isozaki", 
        "givenName": "Eiji", 
        "id": "sg:person.01172632152.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172632152.34"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/mus.20678", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001040933"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jns.2014.11.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007830403"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-4598(199605)19:5<637::aid-mus12>3.0.co;2-k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014969869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s004010050835", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027402983", 
          "https://doi.org/10.1007/s004010050835"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.410360313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028309671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.410260408", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032315578"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1529-8027.2010.00278.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036732560"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1529-8027.2010.00278.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036732560"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/14651858.cd002827.pub3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041468153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-4598(200006)23:6<895::aid-mus8>3.0.co;2-g", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041728163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00878529", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043037921", 
          "https://doi.org/10.1007/bf00878529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/brain/117.5.941", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059439385"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181b59a80", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354585"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181b59a80", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354585"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e3181b59a80", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064354585"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e318296e92b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064357795"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e318296e92b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064357795"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e318296e92b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064357795"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.34.2.218", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064365241"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.54.3.615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064378341"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.56.2.228", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379398"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12", 
    "datePublishedReg": "2017-12-01", 
    "description": "Previous case reports and studies have shown that anti-myelin-associated glycoprotein (MAG) antibody can be detected in patients with polyneuropathy without any detectable M-protein. Nevertheless, the frequency of and related factors have not yet been adequately investigated. The objectives of this study are to examine the prevalence of anti-MAG antibody in patients with demyelinating neuropathy without M-protein and to determine their clinical characteristics. From January, 2004, to September, 2016, consecutive patients with chronic demyelinating neuropathy were recruited. Anti-MAG antibody presence was tested at the first evaluation. We determined the prevalence of anti-MAG antibody without M-protein among included patients and evaluated the clinical characteristics. A total of 44 patients were included in the present study (12 women; median age at first visit 60\u00a0years [interquartile range 47-67\u00a0years]; median duration between onset and first visit 9\u00a0months [3-26\u00a0months]). M-protein was found in eight patients (18%) at the first evaluation. Anti-MAG antibody was present in 2 of remaining 36 (5.6 [95% confidence interval 0-13.0] %) patients without M-protein. Patients with anti-MAG antibody exhibited slowly progressive and distal dominant neuropathy with elevated serum IgM levels and refractory to immunotherapy. There were no differences in clinical features between patients having anti-MAG antibody without M-protein, and those with M-protein. One patient with the anti-MAG antibody showed a delayed appearance of M-protein during a 4-year follow-up after diagnosis. The prevalence of the anti-MAG antibody in chronic demyelinating neuropathy without any detectable M-protein was 5.6%. Anti-MAG antibody may be detectable earlier than M-protein.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10072-017-3133-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1294956", 
        "issn": [
          "1590-1874", 
          "1126-5442"
        ], 
        "name": "Neurological Sciences", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "38"
      }
    ], 
    "name": "Chronic demyelinating neuropathy with anti-myelin-associated glycoprotein antibody without any detectable M-protein", 
    "pagination": "2165-2169", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "3efb6e633dbd00899580b11f4b6cd9c19a398bc64c77b85256522bf5dcc7fe76"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28980134"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100959175"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10072-017-3133-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1092057625"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10072-017-3133-0", 
      "https://app.dimensions.ai/details/publication/pub.1092057625"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000548.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs10072-017-3133-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10072-017-3133-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10072-017-3133-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10072-017-3133-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10072-017-3133-0'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      21 PREDICATES      61 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10072-017-3133-0 schema:about N0d1246c6cea2499aae9413501b627553
2 N1a0763ea7e0e4eb59de101d0122b0a79
3 N1ccb76deb04141a89eb4c2be8d9552a4
4 N1f33007bace9401ca2193921944e3f4f
5 N2413aa2308174c21a1eb01f3d634465a
6 N36a1c19d17b6408792b5b20294261c6e
7 N64e428d885c1477981ae7cdbbf4829e6
8 N6acf0324d40a493c8c389f9a93eaa23b
9 N725368a6f37544409a1a4925e66dd696
10 N876f6298bf45416eba69f69334dacc86
11 N8c497417594e4d298baa26ba98227b46
12 N8dad445342d549d2bc67a2beeeef986c
13 Nbc1ee66026bb43cebc87b9a2f11a8afa
14 Nbce67d65af8d48dfb2673570b8ed0151
15 Nd3f92dead1394d7cbc92d17ce8d2052a
16 Nf0abe2471dec4da19998fe26b715348d
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author N50c2c83a931f45308917444eb62193ff
20 schema:citation sg:pub.10.1007/bf00878529
21 sg:pub.10.1007/s004010050835
22 https://doi.org/10.1002/(sici)1097-4598(199605)19:5<637::aid-mus12>3.0.co;2-k
23 https://doi.org/10.1002/(sici)1097-4598(200006)23:6<895::aid-mus8>3.0.co;2-g
24 https://doi.org/10.1002/14651858.cd002827.pub3
25 https://doi.org/10.1002/ana.410260408
26 https://doi.org/10.1002/ana.410360313
27 https://doi.org/10.1002/mus.20678
28 https://doi.org/10.1016/j.jns.2014.11.006
29 https://doi.org/10.1093/brain/117.5.941
30 https://doi.org/10.1111/j.1529-8027.2010.00278.x
31 https://doi.org/10.1212/wnl.0b013e3181b59a80
32 https://doi.org/10.1212/wnl.0b013e318296e92b
33 https://doi.org/10.1212/wnl.34.2.218
34 https://doi.org/10.1212/wnl.54.3.615
35 https://doi.org/10.1212/wnl.56.2.228
36 schema:datePublished 2017-12
37 schema:datePublishedReg 2017-12-01
38 schema:description Previous case reports and studies have shown that anti-myelin-associated glycoprotein (MAG) antibody can be detected in patients with polyneuropathy without any detectable M-protein. Nevertheless, the frequency of and related factors have not yet been adequately investigated. The objectives of this study are to examine the prevalence of anti-MAG antibody in patients with demyelinating neuropathy without M-protein and to determine their clinical characteristics. From January, 2004, to September, 2016, consecutive patients with chronic demyelinating neuropathy were recruited. Anti-MAG antibody presence was tested at the first evaluation. We determined the prevalence of anti-MAG antibody without M-protein among included patients and evaluated the clinical characteristics. A total of 44 patients were included in the present study (12 women; median age at first visit 60 years [interquartile range 47-67 years]; median duration between onset and first visit 9 months [3-26 months]). M-protein was found in eight patients (18%) at the first evaluation. Anti-MAG antibody was present in 2 of remaining 36 (5.6 [95% confidence interval 0-13.0] %) patients without M-protein. Patients with anti-MAG antibody exhibited slowly progressive and distal dominant neuropathy with elevated serum IgM levels and refractory to immunotherapy. There were no differences in clinical features between patients having anti-MAG antibody without M-protein, and those with M-protein. One patient with the anti-MAG antibody showed a delayed appearance of M-protein during a 4-year follow-up after diagnosis. The prevalence of the anti-MAG antibody in chronic demyelinating neuropathy without any detectable M-protein was 5.6%. Anti-MAG antibody may be detectable earlier than M-protein.
39 schema:genre research_article
40 schema:inLanguage en
41 schema:isAccessibleForFree false
42 schema:isPartOf N6c44257df1dc46b18a6c48df344be856
43 Nfb542cf8ae4643889773b2c6d191a0f9
44 sg:journal.1294956
45 schema:name Chronic demyelinating neuropathy with anti-myelin-associated glycoprotein antibody without any detectable M-protein
46 schema:pagination 2165-2169
47 schema:productId N14408b23635c4414869055ede6d44ce0
48 N5e7727eac7e74526966aef5657833c3d
49 N6844721bc90d4bf1b179146fb380e014
50 Nb03923d599e34907a8e7fbad92cfcfe9
51 Ne473a2dbb69b446e8e28fe2c40f398f8
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092057625
53 https://doi.org/10.1007/s10072-017-3133-0
54 schema:sdDatePublished 2019-04-11T00:22
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher N8cf8920a0f0249f098fa778572d56501
57 schema:url https://link.springer.com/10.1007%2Fs10072-017-3133-0
58 sgo:license sg:explorer/license/
59 sgo:sdDataset articles
60 rdf:type schema:ScholarlyArticle
61 N0d1246c6cea2499aae9413501b627553 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Humans
63 rdf:type schema:DefinedTerm
64 N14408b23635c4414869055ede6d44ce0 schema:name doi
65 schema:value 10.1007/s10072-017-3133-0
66 rdf:type schema:PropertyValue
67 N19283cb230eb471394dcfb08c487aa32 rdf:first sg:person.01172632152.34
68 rdf:rest rdf:nil
69 N1a0763ea7e0e4eb59de101d0122b0a79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Aged
71 rdf:type schema:DefinedTerm
72 N1ccb76deb04141a89eb4c2be8d9552a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Immunotherapy
74 rdf:type schema:DefinedTerm
75 N1f33007bace9401ca2193921944e3f4f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Prevalence
77 rdf:type schema:DefinedTerm
78 N2413aa2308174c21a1eb01f3d634465a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Female
80 rdf:type schema:DefinedTerm
81 N36a1c19d17b6408792b5b20294261c6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Connectin
83 rdf:type schema:DefinedTerm
84 N50c2c83a931f45308917444eb62193ff rdf:first sg:person.01011567726.31
85 rdf:rest N847aa73f2d1f4e71b2fe845d574c9fc9
86 N5e7727eac7e74526966aef5657833c3d schema:name readcube_id
87 schema:value 3efb6e633dbd00899580b11f4b6cd9c19a398bc64c77b85256522bf5dcc7fe76
88 rdf:type schema:PropertyValue
89 N64e428d885c1477981ae7cdbbf4829e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Treatment Failure
91 rdf:type schema:DefinedTerm
92 N6844721bc90d4bf1b179146fb380e014 schema:name dimensions_id
93 schema:value pub.1092057625
94 rdf:type schema:PropertyValue
95 N6acf0324d40a493c8c389f9a93eaa23b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Autoantibodies
97 rdf:type schema:DefinedTerm
98 N6c44257df1dc46b18a6c48df344be856 schema:issueNumber 12
99 rdf:type schema:PublicationIssue
100 N725368a6f37544409a1a4925e66dd696 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Disease Progression
102 rdf:type schema:DefinedTerm
103 N847aa73f2d1f4e71b2fe845d574c9fc9 rdf:first sg:person.015551645122.03
104 rdf:rest N89d2dc6244124432bd1d21423e458847
105 N876f6298bf45416eba69f69334dacc86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Immunoglobulin M
107 rdf:type schema:DefinedTerm
108 N89d2dc6244124432bd1d21423e458847 rdf:first sg:person.01121612173.12
109 rdf:rest N19283cb230eb471394dcfb08c487aa32
110 N8c497417594e4d298baa26ba98227b46 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Retrospective Studies
112 rdf:type schema:DefinedTerm
113 N8cf8920a0f0249f098fa778572d56501 schema:name Springer Nature - SN SciGraph project
114 rdf:type schema:Organization
115 N8dad445342d549d2bc67a2beeeef986c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Follow-Up Studies
117 rdf:type schema:DefinedTerm
118 Nb03923d599e34907a8e7fbad92cfcfe9 schema:name nlm_unique_id
119 schema:value 100959175
120 rdf:type schema:PropertyValue
121 Nbc1ee66026bb43cebc87b9a2f11a8afa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Middle Aged
123 rdf:type schema:DefinedTerm
124 Nbce67d65af8d48dfb2673570b8ed0151 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
126 rdf:type schema:DefinedTerm
127 Nd3f92dead1394d7cbc92d17ce8d2052a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Myelin-Associated Glycoprotein
129 rdf:type schema:DefinedTerm
130 Ne473a2dbb69b446e8e28fe2c40f398f8 schema:name pubmed_id
131 schema:value 28980134
132 rdf:type schema:PropertyValue
133 Nf0abe2471dec4da19998fe26b715348d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Male
135 rdf:type schema:DefinedTerm
136 Nfb542cf8ae4643889773b2c6d191a0f9 schema:volumeNumber 38
137 rdf:type schema:PublicationVolume
138 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
139 schema:name Medical and Health Sciences
140 rdf:type schema:DefinedTerm
141 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
142 schema:name Clinical Sciences
143 rdf:type schema:DefinedTerm
144 sg:journal.1294956 schema:issn 1126-5442
145 1590-1874
146 schema:name Neurological Sciences
147 rdf:type schema:Periodical
148 sg:person.01011567726.31 schema:affiliation https://www.grid.ac/institutes/grid.410821.e
149 schema:familyName Sakamoto
150 schema:givenName Yuki
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011567726.31
152 rdf:type schema:Person
153 sg:person.01121612173.12 schema:affiliation https://www.grid.ac/institutes/grid.417106.5
154 schema:familyName Tobisawa
155 schema:givenName Shinsuke
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121612173.12
157 rdf:type schema:Person
158 sg:person.01172632152.34 schema:affiliation https://www.grid.ac/institutes/grid.417106.5
159 schema:familyName Isozaki
160 schema:givenName Eiji
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172632152.34
162 rdf:type schema:Person
163 sg:person.015551645122.03 schema:affiliation https://www.grid.ac/institutes/grid.417106.5
164 schema:familyName Shimizu
165 schema:givenName Toshio
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015551645122.03
167 rdf:type schema:Person
168 sg:pub.10.1007/bf00878529 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043037921
169 https://doi.org/10.1007/bf00878529
170 rdf:type schema:CreativeWork
171 sg:pub.10.1007/s004010050835 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027402983
172 https://doi.org/10.1007/s004010050835
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1002/(sici)1097-4598(199605)19:5<637::aid-mus12>3.0.co;2-k schema:sameAs https://app.dimensions.ai/details/publication/pub.1014969869
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1002/(sici)1097-4598(200006)23:6<895::aid-mus8>3.0.co;2-g schema:sameAs https://app.dimensions.ai/details/publication/pub.1041728163
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1002/14651858.cd002827.pub3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041468153
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1002/ana.410260408 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032315578
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1002/ana.410360313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028309671
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1002/mus.20678 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001040933
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/j.jns.2014.11.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007830403
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1093/brain/117.5.941 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059439385
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1111/j.1529-8027.2010.00278.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1036732560
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1212/wnl.0b013e3181b59a80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064354585
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1212/wnl.0b013e318296e92b schema:sameAs https://app.dimensions.ai/details/publication/pub.1064357795
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1212/wnl.34.2.218 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064365241
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1212/wnl.54.3.615 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064378341
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1212/wnl.56.2.228 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064379398
201 rdf:type schema:CreativeWork
202 https://www.grid.ac/institutes/grid.410821.e schema:alternateName Nippon Medical School
203 schema:name Department of Neurological Science, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan
204 Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1, Musashidai, 183-0042, Fuchu, Tokyo, Japan
205 rdf:type schema:Organization
206 https://www.grid.ac/institutes/grid.417106.5 schema:alternateName Tokyo Metropolitan Neurological Hospital
207 schema:name Department of Neurology, Tokyo Metropolitan Neurological Hospital, 2-6-1, Musashidai, 183-0042, Fuchu, Tokyo, Japan
208 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...